SOURCE: Medivation


August 08, 2012 17:49 ET

Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA--(Marketwire - Aug 8, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following investor conference:

  • David Hung, M.D., president and chief executive officer, will present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference on Wednesday, August 15 at 8:00am Eastern Time at the Le Parker Meridien in New York City.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at

Contact Information

  • Contacts:
    Patrick Machado
    Chief Business & Financial Officer
    (415) 829-4101

    Anne Bowdidge
    Sr. Director, Investor Relations
    (650) 218-6900